Net Cash Provided by (Used in) Operating Activities |
278M |
USD |
+4.38% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
-45.7M |
USD |
-104% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-2.04B |
USD |
-8.76% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
200M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
170M |
shares |
+0.33% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-1.8B |
USD |
-346% |
Q1 2025 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
4.41B |
USD |
+1.01% |
Q2 2025 |
Q2 2025 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
435M |
USD |
-27.6% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
0 |
USD |
|
Q4 2024 |
FY 2024 |
Deferred Tax Assets, Gross |
601M |
USD |
-1.17% |
Q4 2024 |
FY 2024 |
Operating Lease, Liability |
87M |
USD |
-2.96% |
Q2 2025 |
Q2 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
1.38B |
USD |
+12.8% |
Q2 2025 |
Q2 2025 |
Deferred Income Tax Expense (Benefit) |
-22.5M |
USD |
-225% |
Q1 2025 |
Q1 2025 |
Unrecognized Tax Benefits |
4.67M |
USD |
+291% |
Q4 2024 |
FY 2024 |
Additional Paid in Capital |
2.06B |
USD |
+2.63% |
Q2 2025 |
Q2 2025 |
Depreciation, Depletion and Amortization |
49.4M |
USD |
-4.27% |
Q1 2025 |
Q1 2025 |
Interest Expense |
1.75B |
USD |
+116% |
Q2 2024 |
Q2 2024 |